TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32701512

Group type: EXPERIMENTAL
Intervention: Anastrozole plus estradiol (E2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Anastrozole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Exemestane
Number of subjects: 0

Group type: COMPARATOR
Intervention: Letrozole
Number of subjects: 0
Study: 36113708

Group type: EXPERIMENTAL
Intervention: Craniosacral therapy (CST) sessions (1-3 sessions until symptoms resolved)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 58
Study: 33956873

Group type: EXPERIMENTAL
Intervention: Instructor-led distance learning (DL)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Conventional learning (CL)
Number of subjects: 62
Study: 32025522

Group type: EXPERIMENTAL
Intervention: Korean Red Ginseng (KRG)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 33561085

Group type: EXPERIMENTAL
Intervention: Interval running test (8 bouts of 3 min at 85% of maximal aerobic speed)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Eccentric-based resistance exercise protocol (10 sets of 10 repetitions of plate-loaded barbell parallel back squats at 60% of 1RM)
Number of subjects: 104
Study: 33831317

Group type: EXPERIMENTAL
Intervention: CHO-deficit (treadmill exercise followed by a non-caloric, taste-matched placebo)
Number of subjects: 9

Group type: COMPARATOR
Intervention: CHO-replace (treadmill exercise followed by a carbohydrate replacement drink of 200 or 150 g maltodextrin)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Rest (seated rest with no drink provided)
Number of subjects: 9
Study: 36122810

Group type: EXPERIMENTAL
Intervention: Ingesting 75-g glucose
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: People with excess fat mass
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: High blood glucose or excess body fat
Number of subjects: 44
Study: 33308893

Group type: EXPERIMENTAL
Intervention: Aging and Engaging Program (AEP) - web-based communication coach, delivered with minimal assistance in the home (eight brief sessions over 4–6 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control - education and videos on communication
Number of subjects: 20
Study: 35932992

Group type: EXPERIMENTAL
Intervention: Contralateral neurofeedback training
Number of subjects: 14

Group type: COMPARATOR
Intervention: Ipsilateral neurofeedback training
Number of subjects: 14
Study: 32008886

Group type: EXPERIMENTAL
Intervention: TrueBeam (TB)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Clinac V4
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Clinac V5
Number of subjects: 3

Group type: COMPARATOR
Intervention: Clinacs (V4 and V5)
Number of subjects: 3
Study: 35556054

Group type: EXPERIMENTAL
Intervention: BH4 (Sapropterin, 10 mg/kg)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 32342496

Group type: EXPERIMENTAL
Intervention: Nabiximols (oromucosal cannabinoid medicine), 12 sprays/day max based on clinical response/tolerability for 12 weeks
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Nabiximols
Number of subjects: 72
Study: 35606184

Group type: EXPERIMENTAL
Intervention: Perioperative nutritional supplements
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 71
Study: 33887881

Group type: EXPERIMENTAL
Intervention: Combined training (CT) group
Number of subjects: 64

Group type: COMPARATOR
Intervention: Routine training (RT) group
Number of subjects: 64
Study: 35963411

Group type: EXPERIMENTAL
Intervention: Traffic-related air pollution exposure (main road)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Traffic-free park exposure
Number of subjects: 35
Study: 33483840

Group type: EXPERIMENTAL
Intervention: SW-1 (200 kg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: SW-2 (250 kg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: SW-3 (300 kg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: SW-4 (350 kg)
Number of subjects: 20
Study: 33426079

Group type: EXPERIMENTAL
Intervention: Novel Rhythmic Physical Activities (NRPA)
Number of subjects: 289

Group type: COMPARATOR
Intervention: Traditional Rhythmic Physical Activities (TRPA)
Number of subjects: 289
Study: 36286574

Group type: EXPERIMENTAL
Intervention: Customized Photobiomodulation (PBMT) applied using 850 nm with continuous wave, total of 526-1402 J each session, twice a week for 5 weeks
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Customized Photobiomodulation (PBMT)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo group (sham irradiation)
Number of subjects: 31
Study: 33237990

Group type: EXPERIMENTAL
Intervention: Mindfulness-exercise group (8-week mindfulness intervention + 18 weeks exercise therapy, 3 sessions/week)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Mindfulness-exercise group
Number of subjects: 30

Group type: COMPARATOR
Intervention: Exercise-only group (18 weeks exercise therapy, 3 sessions/week)
Number of subjects: 30
Study: 32915638

Group type: EXPERIMENTAL
Intervention: 6,400 IU/day vitamin D3
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: 2,400 IU/day vitamin D3
Number of subjects: 419

Group type: COMPARATOR
Intervention: 400 IU/day vitamin D3
Number of subjects: 419

Group type: COMPARATOR
Intervention: Placebo for infants in 2,400 and 6,400 IU groups
Number of subjects: 419
Study: 33774458

Group type: EXPERIMENTAL
Intervention: 0.15−0.2 mg/kg nalbuphine
Number of subjects: 30

Group type: COMPARATOR
Intervention: 0.75–1.0 mg/kg tramadol
Number of subjects: 30
Study: 35227795

Group type: EXPERIMENTAL
Intervention: Endovascular recanalization with stenting (EI)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Remote endarterectomy (RE)
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Endovascular reintervention (EI)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Endovascular reintervention (RE)
Number of subjects: 238
Study: 32692747

Group type: EXPERIMENTAL
Intervention: Highest quartile of BMIGPS
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Highest quartile of BMICNS
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Highest quartile of BMInon-CNS
Number of subjects: 397
Study: 34001096

Group type: EXPERIMENTAL
Intervention: Serum CFP-10 signal in HIV-infected infants
Number of subjects: 519

Group type: EXPERIMENTAL
Intervention: Serum CFP-10 signal in HIV-uninfected infants
Number of subjects: 519

Group type: EXPERIMENTAL
Intervention: Serum CFP-10 signal for confirmed and unconfirmed TB
Number of subjects: 519
Study: 34605188

Group type: EXPERIMENTAL
Intervention: TEENS+parent weight loss (PWL; adult behavioural weight loss)
Number of subjects: 82

Group type: COMPARATOR
Intervention: TEENS+parents as coaches (PAC; parent skills training)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: TEENS+parent weight loss (PWL) during maintenance
Number of subjects: 82

Group type: COMPARATOR
Intervention: TEENS+parents as coaches (PAC) during maintenance
Number of subjects: 82
Study: 34241688

Group type: EXPERIMENTAL
Intervention: Combination method cohort using contrast-enhanced ultrasonography (CEUS) and blue dye (BD) together
Number of subjects: 144

Group type: COMPARATOR
Intervention: Single BD method cohort
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: CEUS for SLN diagnosis
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Combination method cohort
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Both cohorts
Number of subjects: 144
Study: 34818112

Group type: EXPERIMENTAL
Intervention: Nivolumab plus ipilimumab
Number of subjects: 945

Group type: EXPERIMENTAL
Intervention: Nivolumab alone
Number of subjects: 945

Group type: COMPARATOR
Intervention: Ipilimumab
Number of subjects: 945
Study: 35582875

Group type: EXPERIMENTAL
Intervention: Directly observed therapy (DOT)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Fortnightly provision
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Fortnightly provision with psychological intervention
Number of subjects: 110

Group type: COMPARATOR
Intervention: Comparison of all groups
Number of subjects: 110
Study: 33290737

Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 328

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 328
Study: 33590471

Group type: EXPERIMENTAL
Intervention: Oxcarbazepine (OXC) monotherapy
Number of subjects: 70

Group type: COMPARATOR
Intervention: Levetiracetam (LEV) monotherapy
Number of subjects: 70
Study: 35086969

Group type: EXPERIMENTAL
Intervention: Optimos™ sphincterotome
Number of subjects: 104

Group type: COMPARATOR
Intervention: CleverCut3™ sphincterotome
Number of subjects: 104
Study: 34444711

Group type: EXPERIMENTAL
Intervention: Berberine (500 mg orally, twice a day)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 36006437

Group type: EXPERIMENTAL
Intervention: (chemo)radiotherapy with larynx V50Gy exceeding 53%
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: (chemo)radiotherapy
Number of subjects: 61
Study: 32433377

Group type: EXPERIMENTAL
Intervention: Microlearning wellness interventions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 36256695

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 3239

Group type: COMPARATOR
Intervention: Prasugrel
Number of subjects: 3239

Group type: EXPERIMENTAL
Intervention: HBR status
Number of subjects: 3239
Study: 34424907

Group type: EXPERIMENTAL
Intervention: HPV-based screening
Number of subjects: 395725

Group type: COMPARATOR
Intervention: Cytology-based screening
Number of subjects: 395725
Study: 32598941

Group type: EXPERIMENTAL
Intervention: Anodal tDCS over the right DLPFC
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham-tDCS (placebo)
Number of subjects: 60
Study: 33136770

Group type: EXPERIMENTAL
Intervention: Rowing
Number of subjects: 22

Group type: COMPARATOR
Intervention: Cycling
Number of subjects: 22
Study: 32316918

Group type: EXPERIMENTAL
Intervention: Audio distraction
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Visual distraction
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Combination of audio and visual distraction
Number of subjects: 289

Group type: COMPARATOR
Intervention: Control group (no distraction)
Number of subjects: 289
Study: 35471708

Group type: EXPERIMENTAL
Intervention: PEEK cages
Number of subjects: 104

Group type: COMPARATOR
Intervention: TC-PEEK cages
Number of subjects: 104
Study: 35118794

Group type: EXPERIMENTAL
Intervention: Shaken baby syndrome prevention program (SBSPP)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 87
Study: 34127362

Group type: EXPERIMENTAL
Intervention: VidaTalk™ application
Number of subjects: 7
Study: 32379695

Group type: EXPERIMENTAL
Intervention: Wrist-ankle acupuncture (WAA) combined with auricular acupuncture (AA)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Wrist-ankle acupuncture (WAA)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Auricular acupuncture (AA)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Conventional analgesia alone (Control Group A)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Wrist-ankle acupuncture (WAA) + Conventional analgesia (Control Group B)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Auricular acupuncture (AA) + Conventional analgesia (Control Group C)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Wrist-ankle acupuncture (WAA) + Auricular acupuncture (AA) + Conventional analgesia (Control Group D)
Number of subjects: 160
Study: 34648051

Group type: EXPERIMENTAL
Intervention: Nomograms predicting overall survival (OS) and cancer-specific survival (CSS)
Number of subjects: 864

Group type: EXPERIMENTAL
Intervention: Low-risk group
Number of subjects: 864

Group type: EXPERIMENTAL
Intervention: Moderate-risk group
Number of subjects: 864
Study: 33272244

Group type: EXPERIMENTAL
Intervention: MASS intervention
Number of subjects: 200
Study: 34847710

Group type: EXPERIMENTAL
Intervention: 2-stage consent process
Number of subjects: 2325

Group type: EXPERIMENTAL
Intervention: Doctor consent
Number of subjects: 2325

Group type: EXPERIMENTAL
Intervention: Relative consent
Number of subjects: 2325

Group type: COMPARATOR
Intervention: 1-stage consent
Number of subjects: 2325

Group type: EXPERIMENTAL
Intervention: 2-stage pathways
Number of subjects: 2325
Study: 34529073

Group type: EXPERIMENTAL
Intervention: Pregnant women with PCOS
Number of subjects: 358

Group type: COMPARATOR
Intervention: Pregnant women without PCOS (controls)
Number of subjects: 358
Study: 33827105

Group type: EXPERIMENTAL
Intervention: PHQ-9 score decreases of 7-9 points
Number of subjects: 906

Group type: EXPERIMENTAL
Intervention: PHQ-9 score decreases of 14-16 points
Number of subjects: 906

Group type: EXPERIMENTAL
Intervention: Univariate analyses of 9 depression treatment metrics
Number of subjects: 906

Group type: EXPERIMENTAL
Intervention: Multivariate models
Number of subjects: 906

Group type: EXPERIMENTAL
Intervention: Absolute score change of 8 points or greater in PHQ-9
Number of subjects: 906
Study: 32434637

Group type: EXPERIMENTAL
Intervention: Vacuum stretcher combined with feeding
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional sedation
Number of subjects: 80
Study: 36106652

Group type: EXPERIMENTAL
Intervention: Insulin icodec
Number of subjects: 6

Group type: COMPARATOR
Intervention: Insulin glargine U100 or U300 or insulin degludec
Number of subjects: 6
Study: 35503653

Group type: COMPARATOR
Intervention: Text messaging-based mindfulness intervention for insomnia
Number of subjects: 919

Group type: COMPARATOR
Intervention: Text messaging-based mindfulness intervention for pain
Number of subjects: 919

Group type: COMPARATOR
Intervention: Text messaging-based mindfulness intervention for dysregulated eating
Number of subjects: 919
Study: 34182951

Group type: EXPERIMENTAL
Intervention: Group B (small tidal volume 8 mL/kg + PEEP 5 cmH2O)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Group C (small tidal volume 8 mL/kg + PEEP 5 cmH2O + recruitment maneuvers)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Group A (conventional mechanical ventilation)
Number of subjects: 90
Study: 34766822

Group type: EXPERIMENTAL
Intervention: Suppression
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Acceptance
Number of subjects: 90

Group type: COMPARATOR
Intervention: Passive Monitoring
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: UIT-related stimuli
Number of subjects: 90
Study: 35074007

Group type: EXPERIMENTAL
Intervention: MindPower intervention (IG1)
Number of subjects: 1673

Group type: COMPARATOR
Intervention: Control group (IG2)
Number of subjects: 1673
Study: 32811272

Group type: EXPERIMENTAL
Intervention: Tai Chi Chuan (TCC) - online 10 week 20 lessons video program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control - educational videos of similar length and frequency
Number of subjects: 0
Study: 36029496

Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control (Placebo)
Number of subjects: 82
Study: 32323940

Group type: EXPERIMENTAL
Intervention: Cortexin
Number of subjects: 74

Group type: COMPARATOR
Intervention: Standard therapy without cortexin (Control)
Number of subjects: 74
Study: 36102864

Group type: EXPERIMENTAL
Intervention: Best-worst
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ranking
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Best-best
Number of subjects: 0

Group type: COMPARATOR
Intervention: All three methods
Number of subjects: 0
Study: 33148247

Group type: EXPERIMENTAL
Intervention: Workplace Mental Health Promotion Programme (12 weeks, including reminder messages, videos, and WhatsApp texts)
Number of subjects: 70
Study: 35665840

Group type: EXPERIMENTAL
Intervention: En-bloc TURBT
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: DEEP scale
Number of subjects: 248
Study: 33175656

Group type: EXPERIMENTAL
Intervention: VGX-3100
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 33276383

Group type: EXPERIMENTAL
Intervention: 4 high-level prognostic metrics (MMP-9, S100A8/A9, hsCRP, GDF-15)
Number of subjects: 3575

Group type: COMPARATOR
Intervention: 1 or 0 high-level prognostic metrics
Number of subjects: 3575
Study: 33201119

Group type: EXPERIMENTAL
Intervention: Prehabilitation (nutritional counseling and exercise)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Standard counseling
Number of subjects: 118
Study: 34700679

Group type: EXPERIMENTAL
Intervention: Curative intent radiation therapy
Number of subjects: 7935

Group type: EXPERIMENTAL
Intervention: Palliative intent radiation therapy
Number of subjects: 7935

Group type: COMPARATOR
Intervention: Overall treatment volume
Number of subjects: 7935

Group type: COMPARATOR
Intervention: Palliative treatment intent
Number of subjects: 7935
Study: 36160134

Group type: EXPERIMENTAL
Intervention: SoC plus nitazoxanide (1,000 mg b.i.d.) and atazanavir/ritonavir (300/100 mg od)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Atazanavir/ritonavir
Number of subjects: 57
Study: 32326954

Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive therapy for PTSD (iCT-PTSD)
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Internet-delivered stress management therapy (iStress-PTSD)
Number of subjects: 217

Group type: COMPARATOR
Intervention: Wait-list condition
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: iCT-PTSD and iStress-PTSD
Number of subjects: 217
Study: 33914991

Group type: EXPERIMENTAL
Intervention: Abemaciclib
Number of subjects: 1284

Group type: COMPARATOR
Intervention: ECOG-PS
Number of subjects: 1284

Group type: EXPERIMENTAL
Intervention: Patient-reported outcomes (PROs)
Number of subjects: 1284
Study: 33167994

Group type: EXPERIMENTAL
Intervention: Genetically predicted ulcerative colitis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetically predicted Crohn’s disease
Number of subjects: 0
Study: 34751786

Group type: EXPERIMENTAL
Intervention: 3D volumetric measurements
Number of subjects: 21

Group type: COMPARATOR
Intervention: 2D LGG RANO
Number of subjects: 21
Study: 33778082

Group type: EXPERIMENTAL
Intervention: Nomogram integrating gender, age of diagnosis, WBC at diagnosis, bone marrow leukemic blast percentage, and chromosomal abnormalities [t(8; 21), inv(16)]
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Web-based survival rate predictor
Number of subjects: 440
Study: 32126336

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy
Number of subjects: 357

Group type: COMPARATOR
Intervention: Psychodynamic therapy
Number of subjects: 357
Study: 35661212

Group type: EXPERIMENTAL
Intervention: Mindfulness Intervention (MI)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 43
Study: 33560320

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (3 × 38 minutes/week)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Moderate Continuous Training (5 × 40 minutes/week)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Guideline Control (1-time advice on physical activity)
Number of subjects: 180
Study: 35835612

Group type: EXPERIMENTAL
Intervention: Intraperitoneal chemotherapy (IP)
Number of subjects: 1174

Group type: COMPARATOR
Intervention: Intravenous chemotherapy (IV)
Number of subjects: 1174
Study: 33370142

Group type: EXPERIMENTAL
Intervention: Gratitude emotional state
Number of subjects: 379

Group type: COMPARATOR
Intervention: Neutral emotional state
Number of subjects: 379
Study: 35192031

Group type: EXPERIMENTAL
Intervention: Orthokeratology (OK) lenses
Number of subjects: 53

Group type: COMPARATOR
Intervention: Multifocal soft contact lenses (MSCLs)
Number of subjects: 53
Study: 34357857

Group type: EXPERIMENTAL
Intervention: Change rate of serum procalcitonin (PCT) level exceeding 50% as the switch point for weaning from mechanical ventilation.
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Study group intervention based on PCT change rate.
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group using pulmonary infection control (PIC) window.
Number of subjects: 140
Study: 35577726

Group type: EXPERIMENTAL
Intervention: Halsted's method with spaced learning
Number of subjects: 20

Group type: COMPARATOR
Intervention: Peyton's method with spaced learning
Number of subjects: 20
Study: 34872895

Group type: EXPERIMENTAL
Intervention: 180 mg of Ellagic Acid (EA) per day for 2 months
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 34328473

Group type: EXPERIMENTAL
Intervention: PS+CA
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: PS+MA
Number of subjects: 42

Group type: COMPARATOR
Intervention: PM+CA
Number of subjects: 42

Group type: COMPARATOR
Intervention: PM+MA
Number of subjects: 42
Study: 34530161

Group type: EXPERIMENTAL
Intervention: CADe colonoscopy first
Number of subjects: 223

Group type: COMPARATOR
Intervention: HDWL colonoscopy first
Number of subjects: 223
Study: 32437074

Group type: EXPERIMENTAL
Intervention: Isavuconazole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ketoconazole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Voriconazole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Itraconazole
Number of subjects: 0
Study: 34981592

Group type: EXPERIMENTAL
Intervention: Patient Centeredness Index (PCI) survey administered to patients with chronic conditions
Number of subjects: 3622
Study: 33812692

Group type: EXPERIMENTAL
Intervention: Ultrasound training program (2 weeks on-site training)
Number of subjects: 18
Study: 33059420

Group type: EXPERIMENTAL
Intervention: Modified conjunctival transplantation and amniotic membrane transplantation combined with use of IFN alpha‐2b eye drops
Number of subjects: 70

Group type: COMPARATOR
Intervention: Pterygium resection combined with conjunctival autograft transplantation
Number of subjects: 70

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 70
Study: 33891473

Group type: EXPERIMENTAL
Intervention: Atezolizumab with or without cobimetinib (experimental arm of IMblaze370)
Number of subjects: 292

Group type: COMPARATOR
Intervention: Control arm of IMblaze370 (regorafenib)
Number of subjects: 292

Group type: COMPARATOR
Intervention: Flatiron Health EC
Number of subjects: 292

Group type: COMPARATOR
Intervention: Clinico-Genomic Database EC
Number of subjects: 292
Study: 35986403

Group type: EXPERIMENTAL
Intervention: Tuina treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Healthcare education group (Control)
Number of subjects: 60
Study: 32239336

Group type: EXPERIMENTAL
Intervention: 1% ACV (T1)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 2% ACV (T2)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: 4% ACV (T3)
Number of subjects: 180

Group type: COMPARATOR
Intervention: 0% ACV (Control)
Number of subjects: 180
Study: 616118370

Group type: EXPERIMENTAL
Intervention: 0.2 mug/d FAc
Number of subjects: 321

Group type: COMPARATOR
Intervention: Sham injection (control)
Number of subjects: 321